Search

everythinglearnresearchcommunity

for

Search:↓

Capivasertib improves survival in certain breast cancer cases but requires careful management of side effects.

Reversed sequential therapy with cyproterone acetate was effective for treating women with hirsutism and related conditions.

The combination therapy effectively treats infertility in PCOS without major side effects.

JAK inhibition may help manage autoimmune conditions in Down syndrome.

Tofacitinib helps regrow hair in severe alopecia patients, but more research is needed.

Combination therapy with steroids and pimecrolimus improved or stabilized hair loss in most patients with Frontal Fibrosing Alopecia, who also had a high rate of hypothyroidism.

Ixekizumab has known and some unexpected side effects.

Alopecia areata can be reversed by JAK inhibitors, promoting hair regrowth.

Six African American women experienced hair loss after switching to a new HIV medication.

A new finasteride treatment may quickly and effectively promote hair regrowth.

Blocking JAK/STAT pathways can help treat hair loss from alopecia areata.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Kang-ai injection with platinum-based chemotherapy improves tumor response and immune function while reducing side effects in advanced lung cancer.

NXC736 significantly reduced hair loss in mice with alopecia areata.

Blocking certain proteins can reduce skin inflammation caused by cancer treatment.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.

Baricitinib can lead to hair regrowth in alopecia areata but may also cause relapses.

Flutamide helps with prostate cancer and some skin conditions but can harm the liver.

Experts created guidelines for who in Australia can get subsidized JAK inhibitor therapy for alopecia areata.

Dual-targeted therapy is effective and safe for difficult-to-treat inflammatory bowel disease.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

New drugs, baricitinib and ritlecitinib, are effective for severe alopecia areata.

JAK inhibitors effectively regrow hair in alopecia areata but hair loss often returns after stopping treatment.

Tofacitinib helped a 19-year-old regrow hair after other treatments failed.

Baricitinib is effective in promoting hair growth in severe alopecia areata.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Ruxolitinib effectively and safely regrows hair in alopecia patients.

A patient's grey hair regained color during treatment with adalimumab.

VYN201 shows promise as a safe and effective treatment for non-segmental vitiligo.